Answers are grounded in this paper and cite their sources.
Introduction Russia's full-scale invasion of Ukraine in February 2022 brought large numbers of war injuries, overcrowded hospitals and transfers of patients across borders, all of which favor the spread of antimicrobial resistance (AMR). Highly resistant Gram-negative bacteria have been reported in war-injured patients inside and outside Ukraine, but national trends before and during the war have not been compared with those of a neighboring country. This study compared AMR in invasive bacterial isolates in Ukraine and Poland before and during the full-scale war. Materials and methods This retrospective study used publicly available, aggregated surveillance data from the World Health Organization (WHO) Regional Office for Europe, the European Antimicrobial Resistance Surveillance Network and the WHO Global Antimicrobial Resistance and Use Surveillance System. Five pathogen-antibiotic combinations were analyzed: carbapenem-resistant Klebsiella pneumoniae , K. pneumoniae with combined resistance, carbapenem-resistant Acinetobacter species, multidrug-resistant Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus . The percentage of resistant isolates in the pre-war period (2019–2021) was compared with the war period (2022–2023) using risk ratios (RR) with 95% confidence intervals (CI), the Cochran-Armitage test for trend and a difference-in-differences analysis. National policy indicators were taken from the Tracking Antimicrobial Resistance Country Self-assessment Survey. Results Carbapenem resistance in K. pneumoniae rose from 61.0% to 71.3% in Ukraine (RR 1.17, 95% CI: 1.07–1.27) and from 12.5% to 17.5% in Poland (RR 1.41, 95% CI: 1.25–1.58). In Poland, most of this increase occurred in 2021, before the invasion, and resistance reached 24.3% in 2025. Carbapenem resistance in Acinetobacter species increased in Ukraine (74.2% to 83.0%) but not in Poland (79.1% to 78.1%), and the change was significantly greater in Ukraine (ratio of odds ratios 1.80, 95% CI: 1.17–2.77). In 2023, Ukraine reported the highest carbapenem resistance of all reporting countries in the WHO European Region for both K. pneumoniae (70.1% for meropenem) and Escherichia coli (10.7%), although it tested about a quarter as many bloodstream isolates per million population as Poland. Both countries reported laws on prescription-only sale of antibiotics and similar self-assessed capacity for infection prevention and control. Conclusions Ukraine entered the full-scale war with very high carbapenem resistance, which rose further during the war, most clearly in Acinetobacter species. In Poland, the increase in carbapenem-resistant K. pneumoniae began before the invasion and continued afterwards. Expanding surveillance and low blood culture rates in Ukraine limit causal conclusions. Stronger infection control, enforcement of prescription-only antibiotic sales and coordinated cross-border surveillance are needed in both countries.
No takes yet. Share an insight, caveat, or question.
Shrreya Jain (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: